Athersys Company

Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life. The product development portfolio of the Company includes MultiStem, a stem cell product, which is being developed as a treatment for multiple disease indications, and is beingevaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial.

Headquarters: United States
Funding Status: N/A
Employee Number: N/A
Investment Stage: N/A
Number Of Exists: N/A
Technology: COVID
Investor Type: N/A
Founded Date: N/A
Industry: Longevity